focus -WSS

focus

author：explore 2025-09-29 16:25:42 - browse：1

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： What to expect at HLTH 2023, the health care industry conference

WSS

Bristol 'take

Physician executives need more than on

How doctors and nurses shape Google's AI

Bristol 'take

European regulators recommend Amylyx's ALS drug be rejected

European regulators recommend Amylyx's ALS drug be rejected

hotspot

focus

explore

Heart attack and stroke risk calculators need revising

Peter Marks talks Operation Warp Speed for Rare Diseases

Anesthesiologist group: stop taking Ozempic before surgery

Bill would stop addiction treatment from triggering child abuse inquiry

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How should state employee insurance handle Wegovy?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

3 questions for the future of Biden's cancer moonshot

The high cost of giving birth even with insurance

Female surgeons have lower rates of long

leisure time

Readout LOUD podcast: Merger Mondays, Ozempic panic

When women are denied an abortion, their children fare worse than peers

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Bristol 'take

Akero's treatment for NASH falls short in cirrhosis study

Histogen: Failed biotech offers rare public look inside

hotspot

hotspot

knowledge

Wikipedia